Ascione, Guido https://orcid.org/0000-0002-7727-0573
Stella, Stefano
Addis, Alessandro
Ajmone Marsan, Nina
Van Hauwermeiren, Hadewych
Granada, Juan F.
Gelpi, Guido
Denti, Paolo
Article History
Received: 23 February 2025
Accepted: 10 November 2025
First Online: 4 February 2026
Declarations
:
: No human studies were carried out by the authors for this article. All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
: P. Denti has received speaker honoraria from Abbott and Edwards Lifesciences; and is a consultant for Pi-Cardia, InnovHeart HRV, Artiness and Approxima. S. Stella is a consultant for InnovHeart HRV and Approxima. G. Gelpi is a consultant for Approxima. N. Ajmone Marsan has received speaker fee from Abbott Vascular, Philips Ultrasound, GE Healthcare and Pfizer; she has also received a research grant from Pfizer, Alnylam, Astra Zeneca, Edwards Lifescience and Pie Medical. J.F. Granada reports institutional grants/research supports from Abbott, Boston Scientific, Medtronic, Edwards; he is also the Co-Founder of Cephea Valve Technologies (Abbott). G. Ascione, A. Addis and H.Van Hauwermeiren have no conflict of interest to declare.